Xenetic Biosciences Inc. (XBIO)
$3.98
$0.08
(2.13%)
As on 14-Sep-2026 09:37EDT
Market cap
$9 Mln
Revenue (TTM)
$3 Mln
P/E Ratio
--
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
1
-
Debt to Equity
0
-
Book Value
$2.6
-
EPS
$-1.2
-
Face value
--
-
Shares outstanding
2,343,181
10 Years Aggregate
CFO
$-55.55 Mln
EBITDA
$-99.44 Mln
Net Profit
$-134.83 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Xenetic Biosciences (XBIO)
| 83.5 | 21.1 | 24.5 | 10.6 | -6.3 | -30.9 | -38.5 |
|
BSE Sensex*
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Xenetic Biosciences (XBIO)
| -45.6 | 15.5 | 21.0 | -77.9 | -36.8 | 41.7 | -92.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Xenetic Biosciences (XBIO)
|
4.0 | 9.1 | 3.3 | -2.5 | -15.6 | -36.8 | -- | 1.6 |
| 81.6 | 11,702.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 25.1 | |
| 261.7 | 17,334.9 | 1,054.4 | 755.9 | 5.7 | -- | 20.2 | 10.3 | |
| 73.6 | 10,255.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 56.2 | 13,905.5 | 2,435.9 | 860.6 | 31.0 | 43 | 17.6 | 7.5 | |
| 107.1 | 12,167.0 | 1,663.7 | 413.6 | 36.3 | 430 | 31.4 | 84.6 | |
| 344.6 | 10,270.8 | 440.5 | 241.5 | 33.4 | 18.7 | 43.3 | 7.6 | |
| 532.1 | 12,348.9 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.5 | |
| 591.6 | 16,398.7 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.5 | 37.5 | |
| 330.6 | 9,341.5 | 0.0 | -339.1 | -- | -30.6 | -- | 7.0 |
Shareholding Pattern
View DetailsAbout Xenetic Biosciences (XBIO)
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and... progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. It has a sublicensing agreement with Takeda Pharmaceutical Co. Ltd, as well as various research, development, license and supply agreements with Serum Institute of India, PJSC Pharmsynthez, and SynBio, LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Read more
-
CEO, President & Director
Mr. Jeffrey F. Eisenberg Esq.
-
CEO, President & Director
Mr. Jeffrey F. Eisenberg Esq.
-
Headquarters
Framingham, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Xenetic Biosciences (XBIO)
What is the current share price of Xenetic Biosciences Inc (XBIO) Today?
The share price of Xenetic Biosciences Inc (XBIO) is $3.98 (NASDAQ) as of 14-Sep-2026 09:37 EDT. Xenetic Biosciences Inc (XBIO) has given a return of -6.29% in the last 3 years.
What is the current PB & PE ratio of Xenetic Biosciences Inc (XBIO)?
Since, TTM earnings of Xenetic Biosciences Inc (XBIO) is negative, P/E ratio is not available.
The P/B ratio of Xenetic Biosciences Inc (XBIO) is 1.62 times as on 11-Sep-2026, a 67 discount to its peers’ median range of 4.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.85 |
0.67 |
2024 |
-1.55 |
1.02 |
2023 |
-1.28 |
0.54 |
2022 |
-0.07 |
0.03 |
2021 |
-0.23 |
0.07 |
What is the 52 Week High and Low of Xenetic Biosciences Inc (XBIO)?
The 52-week high and low of Xenetic Biosciences Inc (XBIO) are Rs 13.93 and Rs 1.90 as of 14-Sep-2026.
What is the market cap of Xenetic Biosciences Inc (XBIO)?
Xenetic Biosciences Inc (XBIO) has a market capitalisation of $ 9 Mln as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Xenetic Biosciences Inc (XBIO)?
Before investing in Xenetic Biosciences Inc (XBIO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.